Abstract
Muscle rigidity associated with antipsychotic drug treatment is believed to result from reduced striatal dopamine neurotransmission. In the current study the regulatory roles of dopamine D1 and D2 receptor subfamilies in the dorsal (DSTR) and ventral striatum (VSTR) and substantia nigra (SN) were investigated on muscle tone, assessed as increases in tonic electromyographic (EMG) activity. Rats were injected with the irreversible D1/D2 antagonist N-ethoxycarbonyl-2-ethoxy, -1,2-dihydroquinoline (EEDQ), the reversible D1 antagonist SCH23390, or D2 antagonist sulpiride. Increased EMG activity was observed following injection of EEDQ and SCH23390 into the SN or VSTR, and sulpiride into the VSTR. Mapping, using quantitative autoradiographic analysis of dopamine receptor occupancy after striatal injections, showed D1 and D2 receptors in discrete ventral sites were associated with EMG increases. Overall the results support roles for dopamine D1and D2 receptors in the ventral striatum, and D1 receptors in the substantia nigra, in the regulation of muscle tone.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Alcock SJ, Crocker AD . (1999): Interactions between striatal acetylcholine and dopamine receptors in motor control. Proc Aust Soc Clin Exp Pharm Toxicol 6: 117
Alexander GE, DeLong MR . (1985): Microstimulation of the primate neostriatum. II. Somatotopic organization of striatal microexcitable zones and their relation to neuronal response properties. J Neurophysiol 53: 1417–1430
Arnt J . (1985): Antistereotypic effects of dopamine D-1 and D-2 antagonists after intrastriatal injection in rats. Pharmacological and regional specificity. Naunyn-Schmiedeberg's Arch Pharmacol 330: 97–104
Baldessarini RJ, Tarsy D . (1980): Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs. Ann Rev Neurosci 3: 23–41
Battaglia G, Norman AB, Newton PL, Creese I . (1986): In vitro and in vivo irreversible blockade of cortical S2 serotonin receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline: a technique for investigating S2 serotonin receptor recovery. J Neurochem 46: 589–593
Beckstead RM, Domesick VB, Nauta WJH . (1979): Efferent connections of the substantia nigra and ventral tegmental area in the rat. Brain Res 175: 191–217
Belleau B, DiTullio V, Godin D . (1969): The mechanism of irreversible adrenergic blockade by N-carbethoxydihydroquinolines—model studies with typical serine hydrolases. Biochem Pharmacol 18: 1039–1044
Bischoff S, Heinrich M, Sonntag J-M, Krauss J . (1986): The D-1 dopamine receptor antagonist SCH23390 also interacts potently with brain serotonin (5-HT2) receptors. Eur J Pharmacol 129: 367–370
Cameron DL, Crocker AD . (1989): Localization of striatal dopamine receptor function by central injection of an irreversible receptor antagonist. Neuroscience 32: 769–778
Carelli RM, West MO . (1991): Representation of the body by single neurons in the dorsal striatum of the awake, unrestrained rat. J Comp Neurol, 309: 231–249
Casey DE . (1989): Clozapine: Neuroleptic-induced EPS and tardive dyskinesia. Psychopharmacol Berl 99: S47–53
Cheramy A, Leviel V, Glowiniski J . (1981): Dendritic release of dopamine in the substantia nigra. Nature 289: 537–542
Chiodo LA, Bunney BS . (1983): Typical and atypical neuroleptics: Differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J Neurosci 3: 1607–1619
Christensen AV, Arnt J, Hyttel J, Larsen J-J, Svendsen O . (1984): Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics. Life Sci 34: 1529–1540
Claghorn J, Honigfield G, Abuzzahab FS Sr, Wang R, Steinbook R, Tuason V, Klerman G . (1987): The risks and benefits of clozapine versus chlorpromazine. J Clin Psychopharmacol 7: 377–384
Cohen LG, Hallett M . (1988): Non-invasive mapping of human motor cortex. Neurology 38: 904–909
Cospito JA, Kultas-Ilinsky K . (1981): Synaptic organisation of motor corticostriatal projections in the rat. Exp Neurol 72: 257–266
Creese I . (1983): Classical and atypical antipsychotic drugs: New insights. TINS 6: 479–481
Creese I, Burt DR, Snyder SH . (1976): Dopamine receptor binding predicts clinical and pharmacological potencies of antipsychotic drugs. Science 192: 481–483
Crocker AD . (1995): A new view of the role of dopamine receptors in the regulation of muscle tone. Clin Exp Pharmacol Physiol 22: 846–850
Crocker AD . (1997): The regulation of motor control: An evaluation of the role of dopamine receptors in the substantia nigra. Rev Neurosci 8: 55–76
Crocker AD, Cameron DL . (1992): Localisation of striatal muscarinic receptors involved in dopamine receptor-mediated behavioural responses. Neurosci Letts 142: 73–76
Crutcher MD, DeLong MR . (1984): Single cell studies of the primate putamen. I. Functional organization. Exp Brain Res 53: 233–243
DeLong MR . (1990): Primate model of movement disorders of basal ganglia origin. TINS 13: 281–285
Donoghue JP, Herkenham M . (1986): Neostriatal projections from individual cortical fields conform to histochemically distinct striatal compartments in the rat. Brain Res 365: 397–403
Double KL, Crocker AD . (1990.): Effects of inactivation of D1 dopamine receptors on stereotypic and thermic responses to quinpirole (LY171555). Neurosci Letts 115: 81–85
Double KL, Crocker AD . (1993): Quantitative electromyographic changes following modification of central dopaminergic transmission. Brain Res 604: 342–344
Double KL, Crocker AD . (1995): Dopamine receptors in the substantia nigra are involved in the regulation of muscle tone. Proc Natl Acad Sci USA 92: 1669–1673
Dragunow M, Robertson GS, Faull RLM, Robertson HA, Jansen K . (1990): D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons. Neuroscience 37: 287–294
Farde L, Nordstrom A-L, Wiesel F-A, Pauli S, Halldin C, Sedvall G . (1992): Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Arch Gen Psychiatry 49: 538–544
Fletcher GH, Starr MS . (1988): Intracerebral SCH 23390 and catalepsy in the rat. Eur J Pharmacol 149: 175–178
Flores G, Valencia J, Rosales MG, Sierra A, Aceves J . (1993): Appearance of EMG activity and motor asymmetry after unilateral lesions of the dopaminergic innervation to the subthalamic nucleus in the rat. Neurosci Letts 162: 153–156
Graybiel AM . (1990): Neurotransmitters and neuromodulators in the basal ganglia. TINS 13: 244–253
Graybiel AM, Ragsdale CW . (1978): Histochemically distinct compartments in the striatum of human, monkey and cat demonstrated by acetylthiocholinesterase staining. Proc Natl Acad Sci USA 75: 5723–5726
Graybiel AM, Ragsdale CW, Moon Edley S . (1979): Compartments in the striatum of the cat observed by retorgrade cell labeling. Exp Brain Res 34: 189–195
Hacksell U, Jackson DM, Mohell N . (1995): Does the dopamine receptor subtype selectivity of antipsychotic agents provide useful leads for the development of novel therapeutic agents? Pharmacol Toxicol 76: 320–324
Hemsley KM, Crocker AD . (1998): The effects of an irreversible dopamine receptor antagonist, N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ), on the regulation of muscle tone in the rat: the role of the substantia nigra. Neurosci Letts 251: 77–80
Hemsley KM, Crocker AD . (1999a): Raclopride and chlorpromazine, but not clozapine, increase muscle rigidity in the rat: Relationship with D2 dopamine receptor occupancy. Neuropsychopharmacol 21: 101–109
Hemsley KM, Crocker AD . (1999b): In which regions of the brain does dopamine regulate the control of muscle tone? Proceedings of the Aust Soc Clin Exp Pharmacol Toxicol 6: 71
Herkenham M, Pert CB . (1981): Mosaic distribution of opiate receptors, parafascicular projections and acetylcholinesterase in rat striatum. Nature 291: 415–417
Hoge SK, Appelbaum P, Lawlor T, Beck JC, Litman R, Greer A, Gutheil TG, Kaplan E . (1990): A prospective multicenter study of patients’ refusal of antipsychotic drugs. J Clin Psych 55: 29–35
Hontanilla B, De Las Heras S, Gimenez-Amaya JM . (1996): A topographic re-evaluation of the nigrostriatal projections to the caudate nucleus in the cat with multiple retrograde tracers. Neuroscience 72: 485–503
Karlsson P, Smith L, Farde L, Harnryd C, Sedvall G, Wiesel F-A . (1995): Lack of apparent antipsychotic effects of D1 dopamine receptor antagonist SCH39166 in acutely ill schizophrenic patients. Psychopharmacol Berl 121: 309–316
Kelley AE, Domesick VB, Nauta WJ . (1982): The amygdalostriatal projection in the rat – an anatomical study by anterograde and retrograde tracing methods. Neuroscience 7: 615–630
Koshikawa N, Aoki S, Hiruta M, Tomiyama K, Kobayashi M, Tsuboi Y, Iwata K, Sumino R, Stephenson JD . (1989): Effects of intrastriatal injections of selective dopamine D-1 and D-2 agonists and antagonists on jaw movements of rats. Eur J Pharmacol 163: 227–236
Kunzle H . (1975): Bilateral projections from precentral motor cortex to the putamen and other parts of the basal ganglia An autoradiographic study in Macaca fascicularis. Brain Res 88: 195–209
Kunzle H . (1977): Projections from the primary somatosensory cortex to basal ganglia and thalamus in the monkey. Exp Brain Res 30: 481–492
LaHoste G, Marshall JF . (1990): Nigral D1 and striatal D2 receptors mediate the behavioural effects of dopamine agonists. Behav Brain Res 38: 233–242
Lee CY, Double KL, Crocker AD . (1995): Expression of stereotyped behaviour requires stimulation of nigral D1 dopamine receptors. Brain Res 681: 205–208
Leysen JE, Janssen PMF, Schotte A, Luyten WHML, Megens AAHP . (1993): Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors. Psychopharmacol Berl 112: S40–S54
Mayorga AJ, Trevitt JT, Conlan A, Gianutsos G, Salamone JD . (1999): Striatal and nigral D1 mechanisms involved in the antiparkinsonian effects of SKF 82958 (APB): Studies of tremulous jaw movements in rats. Psychopharmacol 143: 72–81
McGeorge AJ, Faull RLM . (1989): The organisation of the projection from the cerebral cortex to the striatum in the rat. Neuroscience 29: 503–537
Meller E, Kuga S, Friedhoff AJ, Goldstein M . (1985): Selective D2 dopamine receptor agonists prevent catalepsy induced by SCH 23390, a selective D1 antagonist. Life Sci 36: 1857–1866
Nordstrom A-L, Farde L, Nyberg S, Karlsson P, Halldin C, Sedvall G . (1995): D1, D2 and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients. Am J Psychiatry 152: 1444–1449
Norman AB, Creese I . (1986): Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain. Molec Pharmacol 30: 96–103
Ogren SO, Fuxe K . (1988): D1- and D2-receptor antagonists induce catalepsy via different efferent striatal pathways. Neurosci Letts 85: 333–338
Ogren SO, Lundstrom J, Nilsson LB . (1993): Concentrations of remoxipride and its phenolic metabolites in rat brain and plasma. Relationship to extrapyramidal side effects and atypical antipsychotic profile. J Neural Transm (Gen Sect) 94: 199–216
Ogren SO, Rosen L, Fuxe K . (1994): The dopamine D2 antagonist remoxipride acts in vivo on a subpopulation of dopamine D2 receptors. Neuroscience 61: 269–283
Ossowska K, Karcz M, Wardas J, Wolfarth S . (1990): Striatal and nucleus accumbens D1/D2 dopamine receptors in neuroleptic catalepsy. Eur J Pharmacol 182: 327–334
Paxinos G, Watson C . (1986): The Rat Brain in Stereotaxic Co-ordinates (2nd ed.). Sydney, Academic Press
Peroutka SJ, Snyder SH . (1980): Relationship of neuroleptic drug effects at brain dopamine, serotonin, α-adrenergic and histamine receptors to clinical potency. Am J Psychiatry 127: 1518–1522
Scherer J, Tatsch K, Schwarz J, Oertel WH, Konjarczyk M, Albus M . (1994): D2 dopamine receptor occupancy differs between patients with and without extrapyramidal side effects. Acta Psychiatr Scand 90: 266–268
Schotte A, Janssen PFM, Megans AAHP, Leysen JE . (1993): Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography. Brain Res 631: 191–202
Sedvall G, Farde L, Hall H, Halldin C, Karlsson P, Nordstrom AL, Nyberg S, Pauli S . (1995): Utilization of radioligands in schizophrenia research. Clin Neurosci 3: 112–121
Seeman P, Lee T, Chau Wong M, Wong K . (1976): Antipsychotic doses and neuroleptic/dopamine receptors. Nature 261: 717–718
Sumiyoshi T, Suzuki K, Sakamoto H, Yamaguchi N, Mori H, Shiba D, Yokogawa K . (1995): Atypicality of several antipsychotics on the basis of in vivo dopamine-D2 and serotonin-5HT2 receptor occupancy. Neuropsychopharmacol 12: 57–64
Turski L, Havemann U, Kuschinsky K . (1984): GABAergic mechanisms in mediating muscular rigidity, catalepsy and postural asymmentry in rats: Differences between dorsal and ventral striatum. Brain Res 322: 49–57
Wardas J, Pietraszek M, Ossowska K, Wolfarth S . (1995): Specific involvement of striatal D1 and D2 dopamine receptors in the neuroleptic catalepsy in rats. Pol J Pharmacol 47: 349–353
Webster KE . (1961): Cortico-striate interraelations in the albino rat. J Anat 95: 532–544
Wise SP, Jones EG . (1977): Somatotopic and columnar organization in the corticotectal projection of the rat somatic sensory cortex. Brain Res 133: 233–235
Yurek DM, Hipkens SB . (1994): Intranigral injections of SCH 23390 inhibit SKF 82958-induced rotational behaviour. Brain Res 639: 329–332
Acknowledgements
The financial assistance of the National Health and Medical Research Committee (NMHRC) and the Flinders Medical Centre Foundation is gratefully acknowledged. KMH was a recipient of an NHMRC Biomedical Postgraduate ‘Dora Lush’ Scholarship.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hemsley, K., Crocker, A. Changes in Muscle Tone Are Regulated by D1 and D2 Dopamine Receptors in the Ventral Striatum and D1 Receptors in the Substantia Nigra. Neuropsychopharmacol 25, 514–526 (2001). https://doi.org/10.1016/S0893-133X(01)00245-7
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1016/S0893-133X(01)00245-7
Keywords
This article is cited by
-
Interactions of a medicinal climber Tinospora cordifolia with supportive interspecific plants trigger the modulation in its secondary metabolic profiles
Scientific Reports (2019)
-
Expression pattern of cdkl5 during zebrafish early development: implications for use as model for atypical Rett syndrome
Molecular Biology Reports (2018)
-
Behavioral effects of dopamine receptor inactivation during the adolescent period: age-dependent changes in dorsal striatal D2High receptors
Psychopharmacology (2014)
-
Localization of D1a dopamine receptors on cell bodies and axonal endings in the substantia nigra pars reticulata of the rat
Journal of Neural Transmission (2007)
